Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Employer
- RMIT University
- Karolinska Institutet
- Technical University of Munich
- University of British Columbia
- University of Oslo
- ;
- ; University of Southampton
- ; University of Warwick
- Academic Europe
- CNRS
- Curtin University
- FNRS - WELBIO
- Heidelberg University Hospital
- Helmholtz-Zentrum Dresden-Rossendorf - HZDR - Helmholtz Association
- Ilya Pharma
- Johannes Gutenberg University Mainz •
- Leibniz
- Linköping University
- Radboud University Medical Center (Radboudumc)
- Stockholm University
- TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz •
- Technical University of Denmark
- University Medical Centre Groningen (UMCG)
- University of Basel
- Université de Caen Normandie
- Uppsala University
- 16 more »
- « less
-
Field
-
to study how the immune system can be harnessed to develop cancer immunotherapies. In particular, we are studying how oncolytic virotherapy can be used in synergy with immunotherapy to achieve optimal
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (www.lit.eu ) is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy
-
and Modulation – DTU Health Tech Kgs. Lyngby, Denmark Posted on 05/23/2024 If you are a specialist with interest in stem-cell differential and immunology and T cell driven immunotherapies this project
-
-temporal dynamic organisation of human T cell immunity in tissues. This will bring the next generation of immunotherapies to the level of tissue specificity. The department of Infection Immunology addresses
-
biomarkers for precise disease monitoring. Furthermore, the unique glycan profiles of tumors provide appealing targets for cancer immunotherapy. This project seeks to exploit tumor-specific glycosylation
-
position within a Research Infrastructure? No Offer Description The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (www.lit.eu ) is a biomedical research center focusing on
-
of the diversity within the T cell immune response. Our long-term goal is that the fundamental knowledge we generate will contribute to improved vaccines and immunotherapies. The Gerlach group is part of
-
compounds, cancer or immunotherapy research. The candidate should be familiar with air-sensitive chemistry and general analytical techniques such as FTIR, NMR, electrochemistry, etc. Desirable criteria
-
such as immunotherapies are revolutionising cancer treatment. However, as they are not effective in all patients they should be tailored to the right patients while work to identify new drug targets and
-
. As a PhD candidate you will focus on analyses of patient-related factors for outcome and chemotherapy and immunotherapy treatment response and toxicity in bladder cancer. The candidate will contribute